SB 2549 Enacted
Opioids - As enacted, adds that a healthcare provider who subcontracts through the contracted healthcare vendor with the department of correction may prescribe a buprenorphine product for the treatment of opioid use disorder if other certain listed criteria are met. - Amends TCA Title 53 and Title 63.
Introduced
In Committee
Floor
Crossed Over
Passed
Enacted
Apr 13, 2026 · House
Effective date(s) 04/07/2026
Apr 13, 2026 · House
Pub. Ch. 677
Apr 7, 2026 · House
Signed by Governor.
Mar 27, 2026 · House
Transmitted to Governor for action.
Mar 26, 2026 · House
Signed by H. Speaker
Mar 25, 2026 · Senate
Signed by Senate Speaker
Mar 24, 2026 · House
Enrolled and ready for signatures
Mar 23, 2026 · House
Passed H., Ayes 82, Nays 0, PNV 2
Mar 23, 2026 · House
Subst. for comp. HB.
Mar 19, 2026 · House
Rcvd. from S., held on H. desk.
Mar 16, 2026 · House
Sponsor(s) Added.
Mar 16, 2026 · House
Engrossed; ready for transmission to House
Mar 16, 2026 · Senate
Passed Senate, Ayes 30, Nays 1
Mar 13, 2026 · House
Placed on Senate Regular Calendar for 3/16/2026
Mar 4, 2026 · House
Recommended for passage, refer to Senate Calendar Committee
Feb 25, 2026 · House
Placed on Senate Health and Welfare Committee calendar for 3/4/2026
Feb 25, 2026 · House
Action deferred in Senate Health and Welfare Committee to 3/4/2026
Feb 18, 2026 · House
Placed on Senate Health and Welfare Committee calendar for 2/25/2026
Feb 5, 2026 · Senate
Passed on Second Consideration, refer to Senate Health and Welfare Committee
Feb 2, 2026 · House
Introduced, Passed on First Consideration
Feb 2, 2026 · House
Filed for introduction